| Revenue growth | 30% Y-o-Y for Q4FY26; 11% Y-o-Y for full year FY26. |
|---|---|
| Margins | EBITDA margin at 2.28%, impacted by low-margin initial API sales. |
| Demand visibility | Stability expected in capsule business; API volumes to grow gradually. |
| Management confidence | High; confident in restoring growth and profitability in FY27. |
Growth
Revenue grew 30% Y-o-Y to ₹58.45 Cr; FY26 revenue reached ₹187.20 Cr, up 11% Y-o-Y. Standalone capsule sales boosted by ₹6 Cr deferred revenue.
Outlook
Commissioned new HPMC line for US markets; API commercial production started March 2026. Expects ₹67 Cr PLI incentive over 6 years.
Risks
Y-o-Y EBITDA dropped 70%; PAT and EPS saw significant losses due to operational stabilization costs and API segment ramp-up.
Earnings Call filed with BSE, NSE: NATCAPSUQ. Summary written with AI assistance from the document.
Natural Capsules Ltd: key numbers
- Share price
- ₹169.52
- Market cap
- ₹176.5 Cr
- Revenue (annual)
- ₹187.2 Cr
- Net profit (annual)
- ₹-24.66 Cr
- P/E (TTM)
- -8.2×Sector 50.4×
- Promoter holding
- 50.92%-0.12% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Natural Capsules Ltd
All →Natural Capsules Annual General Meeting
Natural Capsules Ltd dispatched a corrigendum to its upcoming EGM notice, revising the issue price and quantity for the proposed preferential allotment of shares and warrants.
Natural Capsules Fund Raise of ₹10.01 Cr
Natural Capsules Limited approved a revised preferential issue of 1,12,500 equity shares and 4,50,000 convertible warrants. The total aggregate fund raise is valued at Rs. 10.01 Crore.
- Value
- ₹10.01 Cr
Natural Capsules Investor Presentation: Key Takeaways
NCL reported Q1FY27 revenue of ₹48.71 Cr (+8% Y-o-Y) with EBITDA at ₹1.12 Cr. Strategy focuses on scaling steroidal API volumes and HPMC line conversions to optimize capacity.
Natural Capsules Q1 FY27 Results: Net Loss of ₹5.7 Cr, Loss Widens
Natural Capsules Ltd reported revenue from operations of ₹48.7 Cr (+7.7% YoY) and a net loss of ₹5.7 Cr for Q1 FY27.
- Key figure
- Net loss ₹5.7 Cr
Natural Capsules Earnings Call: Key Takeaways
Natural Capsules Ltd reported Q4 FY26 revenue of ₹58.45cr (up 55% QoQ). Full-year FY26 revenue grew 11% to ₹187.20cr, though the company posted a net loss of ₹24.66cr.
Natural Capsules Q4 FY26 Results: Net Loss of ₹5 Cr
Natural Capsules Ltd reported revenue from operations of ₹58.5 Cr (+30.0% YoY) and a net loss of ₹5 Cr for Q4 FY26.
- Key figure
- Net loss ₹5 Cr